US Markets
PFE

Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later

Credit: REUTERS/CARLO ALLEGRI

U.S. President Donald Trump on Monday suggested Pfizer Inc could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.

WASHINGTON, Sept 21 (Reuters) - U.S. President Donald Trump on Monday suggested Pfizer Inc PFE.N could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson JNJ.N could come later.

Asked which drugmaker could be approved, Trump told Fox News in an interview: "Pfizer's doing really well," adding "Johnson & Johnson ... they'll probably be a little later." He also cited efforts by Moderna Inc MRNA.O and AstraZeneca Plc AZN.L.

(Reporting by Susan Heavey)

((sheavey@thomsonreuters.com; +1 202 843 6600;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PFE JNJ MRNA AZN

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More